Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-109941

Chief Operating Officer gave up 1,395 shares (to pay taxes)

  • Chief Operating Officer acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BILINSKY IGOR Chief Operating Officer 2023-10-16 Option exercise +2,813 30,026 D
BILINSKY IGOR Chief Operating Officer 2023-10-16 Shares withheld for taxes −1,395 $3.57 $4,980 28,631 D
Derivatives
BILINSKY IGOR Chief Operating Officer 2023-10-16 Option exercise · Restricted Stock Units −2,813 14,064 D
Loading xslF345X05/tm2328751-2_4seq1.xml…